Autres langues Rekvina Laboratories Limited

Actions

526075

INE092O01028

Marché Fermé - Bombay S.E. 12:02:27 02/09/2026			Varia. 5j.	Varia. 1 janv.
51,75 ^INR	+1,99%		+10,34%	+1 050,00%

13/08	Rekvina Laboratories Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
13/08	Rekvina Laboratories Limited annonce la nomination de Surbhit Shah à la présidence du conseil d'administration	CI

Autres langues

13/08	Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
13/08	Rekvina Laboratories Limited Announces Appointment of Surbhit Shah as Chairman of the Board
14/07	Surbhit Mukesh Shah, the managing director of Rekvina Laboratories Limited, Amit Mukesh Shah, the director of Rekvina Laboratories Limited and Dhruvalkumar Patel completed the acquisition of an additional 23.22% stake in Rekvina Laboratories Limited for INR 14.41 million.
21/05	Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
16/03	Rekvina Laboratories Limited entered into agreement to acquire Radiant Parenterals Limited from Surbhit Mukesh Shah, Amit Mukesh Shah, Dhruvalkumar Patel, Krima Surbhit Shah and Ami Amit Shah for approximately INR 140 million.
16/03	Surbhit Mukesh Shah and Amit Mukesh Shah, the directors of Rekvina Laboratories Limited and Dhruvalkumar Patel proposed to acquire an additional 47.94% stake in Rekvina Laboratories Limited for INR 28.9 million.
11/03	Rekvina Laboratories Limited announced that it expects to receive INR 4.6 million in funding
06/02	Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
29/01	Rekvina Laboratories Limited Announces the Resignation of Chetanbhai Jayantibhai Patel as Non- Executive Independent Director and from Membership in Various Committees, Effective from 29 January 2026
09/01	Rekvina Laboratories Limited Announces Resignation of Dhruvalkumar Jayantilal Patel as Non-Executive Independent Director, Effective January 9, 2026
14/11	Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
20/09/25	Rekvina Laboratories Limited Announces Shifting of the Registered Office
13/08/25	Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
04/08/25	Rekvina Laboratories Limited Approves Shifting of the Registered Office
30/05/25	Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
20/01/25	Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
04/12/24	Rekvina Laboratories Limited Appoints Deepak Khandelwal Company Secretary and Compliance Officer
14/11/24	Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
05/10/24	Rekvina Laboratories Limited Announces Appointment of Ilaben Pathak as the Chairman of the Board
05/10/24	Rekvina Laboratories Limited Announces Change in Registered Office Address
30/09/24	Rekvina Laboratories Limited Announces Resignation of Srishty Bansal as Company Secretary
30/09/24	Rekvina Laboratories Limited Announces Demise of Mukesh Jamnadas Shah, Vice Chairman and Director
03/09/24	Rekvina Laboratories Appoints CFO
03/09/24	Rekvina Laboratories Limited Approves Appointment of Surbhit Shah as Chief Financial Officer
01/09/24	Rekvina Laboratories Limited Announces Resignation of Pravin Chuahan as Chief Financial Officer